Magnetic cell labeling is the fundamental principle behind MRI-based cell tracking. We have previously described the design, fabrication, and characterization of poly(D,L-lactide-co-glycolide) (PLGA) encapsulated iron oxide nanoparticles (NPs) dedicated for magnetic cell labeling (1). PLGA NPs have been extensively used in the pharmaceutical field for drug delivery, however, they are limited by physical instability (aggregation/particle fusion) and chemical instability (drug leakage of NPs) of the aqueous suspension for extended periods. Freeze drying, or lyophilization, of NPs improves long term stability, but also exacerbates aggregation and nanoparticle fusion. The addition of cryoprotectants to the freeze drying process has been shown to prevent NP aggregation and preserve initial NP formulation characteristics (2). We hypothesized that the addition of cryoprotectants would reduce particle aggregation upon suspension of particles in aqueous media, however it was difficult to predict how this might affect magnetic cell labeling. Therefore, we further sought to investigate the consequences of cryoprotection of PLGA encapsulated iron oxide particles on magnetic cell labeling.
Comparison of average particle sizes before freeze drying and after, with and without cryoprotection. Axes compares size as well as size ratios of particle size after freeze drying and initial particle size, Sf/Si. 
